Evaluation of a Potential Tigecycline‐Warfarin Drug Interaction

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pharmacotherapy

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1592/phco.28.7.895PMID 18576904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections

  2007cited by this paper
• Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Intra-Abdominal Infections

  2007cited by this paper
• Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects

  2007cited by this paper
• Effect of Tigecycline on Normal Oropharyngeal and Intestinal Microflora

  2006cited by this paper
• Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.

  2005cited by this paper
• Molecular spectroscopic study on the interaction of tetracyclines with serum albumins.

  2005cited by this paper
• Systematic overview of warfarin and its drug and food interactions.

  2005cited by this paper
• In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections.

  2005cited by this paper
• Structural basis of the drug-binding specificity of human serum albumin.

  2005cited by this paper
• Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

  2005cited by this paper
• Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

  2005cited by this paper
• A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]

  2005cited by this paper
• Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

  2004cited by this paper
• In Vitro Activities of Tigecycline against Erythromycin-Resistant Streptococcus pyogenes and Streptococcus agalactiae: Mechanisms of Macrolide and Tetracycline Resistance

  2004cited by this paper
• Antibiotics acting on the translational machinery

  2003cited by this paper
• Interdomain zinc site on human albumin

  2003cited by this paper
• Activities of Tigecycline (GAR-936) against Legionella pneumophila In Vitro and in Guinea Pigs with L. pneumophila Pneumonia

  2003cited by this paper
• Activity of Tigecycline (GAR-936), a Novel Glycylcycline, against Enterococci in the Mouse Peritonitis Model

  2003cited by this paper
• New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.

  2002cited by this paper
• Stereoselective kinetics of warfarin binding to human serum albumin: effect of an allosteric interaction.

  2002cited by this paper
• Antithrombotic agents in coronary artery disease.

  2001cited by this paper
• Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

  2001cited by this paper
• In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamases

  2001cited by this paper
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

  2001cited by this paper
• Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance

  2001cited by this paper
• In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.

  2001cited by this paper
• Antithrombotic therapy for venous thromboembolic disease.

  2001cited by this paper
• Antithrombotic therapy in atrial fibrillation.

  2001cited by this paper
• In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.

  2000cited by this paper
• In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae.

  1998cited by this paper
• Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.

  1997cited by this paper
• Human P450 metabolism of warfarin.

  1997cited by this paper
• Characterization of site I on human serum albumin: concept about the structure of a drug binding site.

  1996cited by this paper
• Antithrombotic therapy in atrial fibrillation.

  1996cited by this paper
• Antithrombotic therapy for venous thromboembolic disease.

  1995cited by this paper
• A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter

  1995cited by this paper
• Zinc(II) and copper(II) binding to serum albumin. A comparative study of dog, bovine, and human albumin.

  1994cited by this paper
• Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines

  1994cited by this paper
• Drug interactions with warfarin

  1993cited by this paper
• Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.

  1993cited by this paper
• Antithrombotic agents in coronary artery disease.

  1989cited by this paper
• Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin.

  1989cited by this paper
• Clinical Pharmacokinetics of Doxycycline and Minocycline

  1988cited by this paper
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

  1987cited by this paper
• Pharmacodynamics of Warfarin at Steady State

  1987cited by this paper
• Pharmacokinetic implications of stereoselective changes in plasma-protein binding: warfarin/sulfinpyrazone.

  1984cited by this paper
• Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.

  1983cited by this paper
• Structural requirements for drug binding to site II on human serum albumin.

  1983cited by this paper
• Drug Interactions with Warfarin

  1983cited by this paper
• Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.

  1982cited by this paper
• Protein binding of warfarin enantiomers in serum of humans and rats

  1977cited by this paper
• The stereoselective interaction of warfarin and metronidazole in man.

  1976cited by this paper
• Binding‐site interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cells

  1975cited by this paper
• Comparison of amikacin and gentamicin

  1975cited by this paper
• Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

  1974cited by this paper
• Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

  1974cited by this paper
• Studies on the optical enantiomorphs of warfarin in man.

  1974cited by this paper
• Studies on the optical enantiomorphs of warfarin in man

  1974cited by this paper
• Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols.

  1973cited by this paper
• Kinetics of warfarin absorption in man

  1973cited by this paper
• THROMBOEMBOLIC DISORDERS.

  1964cited by this paper
• Studies on the 4-Hydroxycoumarins. XVII.1a The Resolution and Absolute Configuration of Warfarin1b

  1961cited by this paper
• Mediation of Divalent Metal Ions in the Binding of Tetracycline to Macromolecules

  1961cited by this paper

• Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study

  2023cites this paper
• The Development of Third-Generation Tetracycline Antibiotics and New Perspectives

  2021cites this paper
• Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review

  2021cites this paper
• Pharmacokinetic Drug-drug Interaction of Antibiotics Used in Sepsis Care in China.

  2020cites this paper
• Beware of drug interaction between tigecycline and tacrolimus

  2019cites this paper
• Tigecycline: a critical safety review

  2015cites this paper
• Adjunctive Hyperbaric Oxygen Therapy or Alone Antibiotherapy? Methicillin Resistant Staphylococcus aureus Mediastinitis in a Rat Model

  2015cites this paper
• Phase 1 Study of the Effect of Icosapent Ethyl on Warfarin Pharmacokinetic and Anticoagulation Parameters

  2014cites this paper
• The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.

  2012cites this paper
• Influence of ORM1 polymorphisms on the maintenance stable warfarin dosage

  2012cites this paper
• Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline).

  2011cites this paper
• Review of Tigecycline: Focus on Clinical Utilization

  2010cites this paper
• Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline

  2010cites this paper
• Tetracyclines and Chloramphenicol

  2010cites this paper
• Macrolides, Ketolides, and Glyc ylcy clines: Azithromycin, Clarithromycin, Telithromycin,

  2009cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2009cites this paper
• Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.

  2009cites this paper
• A review of tigecycline--the first glycylcycline.

  2008cites this paper